Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 40 non-cytoplasmic 41 65 transmembrane 66 85 cytoplasmic 86 109 transmembrane 110 115 non-cytoplasmic 116 139 transmembrane 140 149 cytoplasmic 150 172 transmembrane 173 190 non-cytoplasmic 191 210 transmembrane 211 222 cytoplasmic 223 248 transmembrane 249 272 non-cytoplasmic 273 296 transmembrane 297 320 cytoplasmic 321 341 transmembrane 342 352 non-cytoplasmic 353 375 transmembrane 376 384 cytoplasmic 385 404 transmembrane 405 409 non-cytoplasmic 410 428 transmembrane 429 443 cytoplasmic
Input: >Pf1N1B4_4994 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4994 MADSSKKMSLMGLTTLVTVNMMGSGIIMLPTSMAQLGAVSLLSWIVTAVGSMAIAYCFSQ CGIYCLHSGGLSAYTEEAHAKSGFFLCSYLYFLSLGIANVAVAISAVGYMTSFVPWLGSG AIPLFIGTVGLLWLTTMANFGGPGITGKIGAITVWGVIIPVAGLSIIGWFWFKPDVLIAA WNPNSLPISDAISKAIPLTLWAFLGMESAAQASDAVEDPKRTVPLACLFGTMGAAVVYVL STTVIQGIVPNAELANSSAPFALVYAHMFTPTVGNIVMALAVMACVGSLLGWQFTLAQTA KMTADRGMFPKLFSKVSTQNAPILGMLVCGVFQTLMALSTISPNASAQFGKLVSLAAVTN LIPYVTAATGLLVMMYKAKVSTGIYTRNTMVLLIGVGYSLYALYACGKDAVFGGLIVLAF GYLLYGFLSKRFVDLSPIRGGNP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server